home
RSS
November 19th, 2010
11:50 AM ET

Darvon, Darvocet to be pulled from U.S. market

Xanodyne Pharmaceuticals Inc. - the maker of Darvon and Darvocet, the brand version of the prescription pain medication propoxyphene - has agreed to withdraw the medication from the U.S. market at the request of the U.S. Food and Drug Administration, the FDA said on Friday.

The FDA sought the action after new clinical data showed the drug puts patients at risk of potentially serious or even fatal heart rhythm abnormalities.

 Post by:
Filed under: Drug Safety • Food and Drug Administration • Medications
Next entry »
« Previous entry
soundoff (165 Responses)
  1. Tritreviewifind

    https://tadagatadalafil.com/ tadalafil https://apcalisetadalafil.com/ – cialis tadalafil cost tadalafil generic

    May 27, 2021 at 07:11 | Report abuse | Reply
  2. favipiravir

    is chloroquine phosphate over the counter methotrexate chloroquine moa

    June 6, 2021 at 15:43 | Report abuse | Reply
  3. tadalafil goodrx

    tadalista 20 side effects for tadalafil maximpeptide review

    June 6, 2021 at 21:10 | Report abuse | Reply
  4. dolquine

    what is hydroxychloroquine prescribed for malaraquin hydroxyclorine

    June 7, 2021 at 23:11 | Report abuse | Reply
1 2 3

Post a comment


  

CNN welcomes a lively and courteous discussion as long as you follow the Rules of Conduct set forth in our Terms of Service. Comments are not pre-screened before they post. You agree that anything you post may be used, along with your name and profile picture, in accordance with our Privacy Policy and the license you have granted pursuant to our Terms of Service.

Next entry »
« Previous entry
Advertisement
About this blog

Get a behind-the-scenes look at the latest stories from CNN Chief Medical Correspondent, Dr. Sanjay Gupta, Senior Medical Correspondent Elizabeth Cohen and the CNN Medical Unit producers. They'll share news and views on health and medical trends - info that will help you take better care of yourself and the people you love.